Literature DB >> 24421865

Dermatofibrosarcoma protuberans in a 10-year-old child.

Uwe Wollina1.   

Abstract

BACKGROUND: Dermatofibrosarcoma protuberans is a rare mesenchymal malignancy in childhood and adolescence. The tumor is characterized by dermal spindle cell proliferation with infiltration of subcutaneous tissue, expression of CD34, and a specific fusion of the platelet-derived growth factor beta with the collagen type 1alpha1 gene. MAIN OBSERVATION: We observed a 10-year-old girl with a medaillon-like, asymptomatic plaque on the chest that was diagnosed as DSFP. The tumor was completely removed by delayed Mohs surgery. Follow-up so far has shown a complete response.
CONCLUSIONS: The prognosis of dermatofibrosarcoma protuberans in children is excellent as long as early diagnosis is followed by complete excision with Mohs surgery as a golden standard.

Entities:  

Keywords:  child; dermatofibrosarcoma protuberans; surgery; tumor

Year:  2013        PMID: 24421865      PMCID: PMC3888781          DOI: 10.3315/jdcr.2013.1160

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  26 in total

1.  Pediatric dermatofibrosarcoma protuberans: multi-institutional outcomes.

Authors:  Corey W Iqbal; Shawn St Peter; Michael B Ishitani
Journal:  J Surg Res       Date:  2011-02-22       Impact factor: 2.192

2.  Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002.

Authors:  Vincent D Criscione; Martin A Weinstock
Journal:  J Am Acad Dermatol       Date:  2006-12-01       Impact factor: 11.527

3.  Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans.

Authors:  Victoria E Price; Jonathan A Fletcher; Maria Zielenska; William Cole; Sandra Viero; David E Manson; Mary Stuart; Alberto S Pappo
Journal:  Pediatr Blood Cancer       Date:  2005-05       Impact factor: 3.167

4.  Status report on the management of dermatofibrosarcoma protuberans: is there a viable role for the use of imatinib mesylate? In which cases may it be therapeutically helpful and in which cases not?

Authors:  Grace K Kim
Journal:  J Clin Aesthet Dermatol       Date:  2011-03

5.  A clinical, histologic, and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans.

Authors:  Georges Maire; Sylvie Fraitag; Louise Galmiche; Frédérique Keslair; Nathalie Ebran; Marie-José Terrier-Lacombe; Yves de Prost; Florence Pedeutour
Journal:  Arch Dermatol       Date:  2007-02

6.  Excellent survival of pediatric dermatofibrosarcoma protuberans in Taiwanese.

Authors:  Chun-Ru Chien; Yih-Leong Chang; Dong-Tsamnn Lin; Rong-Sen Yang
Journal:  Pediatr Surg Int       Date:  2006-11-16       Impact factor: 1.827

Review 7.  Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.

Authors:  A Paradisi; D Abeni; A Rusciani; E Cigna; M Wolter; N Scuderi; L Rusciani; R Kaufmann; M Podda
Journal:  Cancer Treat Rev       Date:  2008-08-05       Impact factor: 12.111

8.  Dermatofibrosarcoma protuberans in children.

Authors:  Chaitan Reddy; Peter Hayward; Phillip Thompson; Alex Kan
Journal:  J Plast Reconstr Aesthet Surg       Date:  2007-12-21       Impact factor: 2.740

9.  Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.

Authors:  Stephen N Snow; Ellen M Gordon; Paul O Larson; Mohammed M Bagheri; Michael L Bentz; David B Sable
Journal:  Cancer       Date:  2004-07-01       Impact factor: 6.860

10.  Treatment of dermatofibroma sarcoma protuberans using modified Mohs micrographic surgery: no recurrences and smaller defects.

Authors:  John G Hancox; Ben Kelley; Hubert T Greenway
Journal:  Dermatol Surg       Date:  2008-03-03       Impact factor: 3.398

View more
  1 in total

1.  Photoletter to the editor: Pigmented dermatofibrosarcoma protuberans in a 4-year-old girl and ultrasonographic findings.

Authors:  Ryo Tanaka; Kiichi Inagawa; Naoki Kanomata; Jiro Hata; Wataru Fujimoto
Journal:  J Dermatol Case Rep       Date:  2015-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.